COPD can strike at any time, although you are more at risk as you get older. There have been rare cases of COPD in people’s 20s and 30s, but it is not uncommon for people in their 40s to develop the disease.
Positive phase 3 clinical trial data of COPD therapy Revefenacin reported by Theravance and Mylan.